NICE Pans Roche’s MabThera For Vasculitis Due To Lack Of Evidence
This article was originally published in The Pink Sheet Daily
Executive Summary
Britain’s NICE has rejected Roche’s MabThera in the ANCA-associated vasculitis setting, citing too many evidence gaps in the manufacturer’s submission.